2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou5f1
|
ENSMUSG00000024406.10 | POU domain, class 5, transcription factor 1 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_110399115 | 2.74 |
ENSMUST00000020949.5
ENSMUST00000100260.1 |
Map2k6
|
mitogen-activated protein kinase kinase 6 |
chr5_+_21372642 | 2.69 |
ENSMUST00000035799.5
|
Fgl2
|
fibrinogen-like protein 2 |
chr11_-_69605829 | 2.09 |
ENSMUST00000047889.6
|
Atp1b2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
chr8_+_54954728 | 2.00 |
ENSMUST00000033915.7
|
Gpm6a
|
glycoprotein m6a |
chr5_-_123865491 | 1.79 |
ENSMUST00000057145.5
|
Niacr1
|
niacin receptor 1 |
chr15_-_100599983 | 1.75 |
ENSMUST00000073837.6
|
Pou6f1
|
POU domain, class 6, transcription factor 1 |
chr6_-_138421379 | 1.55 |
ENSMUST00000163065.1
|
Lmo3
|
LIM domain only 3 |
chr3_+_96219858 | 1.54 |
ENSMUST00000073115.4
|
Hist2h2ab
|
histone cluster 2, H2ab |
chr2_-_25196759 | 1.49 |
ENSMUST00000081869.6
|
Tor4a
|
torsin family 4, member A |
chr5_+_66968416 | 1.42 |
ENSMUST00000038188.7
|
Limch1
|
LIM and calponin homology domains 1 |
chr13_+_89540636 | 1.41 |
ENSMUST00000022108.7
|
Hapln1
|
hyaluronan and proteoglycan link protein 1 |
chr2_-_103303179 | 1.40 |
ENSMUST00000090475.3
|
Ehf
|
ets homologous factor |
chr8_-_90908415 | 1.37 |
ENSMUST00000098517.1
|
Gm6658
|
predicted gene 6658 |
chr19_+_56287911 | 1.35 |
ENSMUST00000095948.4
|
Habp2
|
hyaluronic acid binding protein 2 |
chr3_-_96220880 | 1.31 |
ENSMUST00000090782.3
|
Hist2h2ac
|
histone cluster 2, H2ac |
chr2_-_103303158 | 1.31 |
ENSMUST00000111176.2
|
Ehf
|
ets homologous factor |
chr7_-_30856178 | 1.30 |
ENSMUST00000094583.1
|
Ffar3
|
free fatty acid receptor 3 |
chr4_-_129623870 | 1.27 |
ENSMUST00000106035.1
ENSMUST00000150357.1 ENSMUST00000030586.8 |
Ccdc28b
|
coiled coil domain containing 28B |
chr10_+_115817247 | 1.25 |
ENSMUST00000035563.7
ENSMUST00000080630.3 ENSMUST00000179196.1 |
Tspan8
|
tetraspanin 8 |
chr9_+_59578192 | 1.24 |
ENSMUST00000118549.1
ENSMUST00000034840.3 |
Celf6
|
CUGBP, Elav-like family member 6 |
chr7_-_29168647 | 1.21 |
ENSMUST00000048923.6
|
Spred3
|
sprouty-related, EVH1 domain containing 3 |
chr11_-_119086221 | 1.18 |
ENSMUST00000026665.7
|
Cbx4
|
chromobox 4 |
chr18_+_37484955 | 1.16 |
ENSMUST00000053856.4
|
Pcdhb17
|
protocadherin beta 17 |
chr4_-_133263042 | 1.16 |
ENSMUST00000105908.3
ENSMUST00000030674.7 |
Sytl1
|
synaptotagmin-like 1 |
chr11_-_58613481 | 1.16 |
ENSMUST00000048801.7
|
2210407C18Rik
|
RIKEN cDNA 2210407C18 gene |
chr3_+_60081861 | 1.11 |
ENSMUST00000029326.5
|
Sucnr1
|
succinate receptor 1 |
chr17_+_28207778 | 1.10 |
ENSMUST00000002327.5
|
Def6
|
differentially expressed in FDCP 6 |
chr6_-_30693676 | 1.09 |
ENSMUST00000169422.1
ENSMUST00000115131.1 ENSMUST00000115130.2 ENSMUST00000031810.8 |
Cep41
|
centrosomal protein 41 |
chr3_+_125404292 | 1.08 |
ENSMUST00000144344.1
|
Ndst4
|
N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 4 |
chr12_-_101819048 | 1.06 |
ENSMUST00000021603.8
|
Fbln5
|
fibulin 5 |
chr2_-_26092149 | 1.05 |
ENSMUST00000114159.2
|
Nacc2
|
nucleus accumbens associated 2, BEN and BTB (POZ) domain containing |
chr11_-_3504766 | 1.04 |
ENSMUST00000044507.5
|
Inpp5j
|
inositol polyphosphate 5-phosphatase J |
chr2_+_155381808 | 1.04 |
ENSMUST00000043237.7
ENSMUST00000174685.1 |
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr1_-_168431896 | 1.04 |
ENSMUST00000176540.1
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chr15_+_57694651 | 1.03 |
ENSMUST00000096430.4
|
Zhx2
|
zinc fingers and homeoboxes 2 |
chr1_-_168431502 | 1.03 |
ENSMUST00000064438.4
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chr14_+_66868850 | 1.01 |
ENSMUST00000100453.1
|
Gm5464
|
predicted gene 5464 |
chr8_+_76902277 | 0.98 |
ENSMUST00000109912.1
ENSMUST00000128862.1 ENSMUST00000109911.1 |
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr15_-_100599864 | 0.96 |
ENSMUST00000177247.2
ENSMUST00000177505.2 |
Pou6f1
|
POU domain, class 6, transcription factor 1 |
chr16_-_22439570 | 0.95 |
ENSMUST00000170393.1
|
Etv5
|
ets variant gene 5 |
chr9_+_53301571 | 0.94 |
ENSMUST00000051014.1
|
Exph5
|
exophilin 5 |
chr17_-_91092715 | 0.88 |
ENSMUST00000160800.2
ENSMUST00000159778.1 ENSMUST00000160844.3 |
Nrxn1
|
neurexin I |
chr14_+_70890099 | 0.87 |
ENSMUST00000022699.8
|
Gfra2
|
glial cell line derived neurotrophic factor family receptor alpha 2 |
chr7_+_81213567 | 0.86 |
ENSMUST00000026672.7
|
Pde8a
|
phosphodiesterase 8A |
chr8_+_22808275 | 0.85 |
ENSMUST00000068068.4
|
1700041G16Rik
|
RIKEN cDNA 1700041G16 gene |
chr3_+_125404072 | 0.84 |
ENSMUST00000173932.1
|
Ndst4
|
N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 4 |
chr17_+_47140942 | 0.79 |
ENSMUST00000077951.7
|
Trerf1
|
transcriptional regulating factor 1 |
chr2_+_155382186 | 0.78 |
ENSMUST00000134218.1
|
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr3_-_84220853 | 0.77 |
ENSMUST00000154152.1
ENSMUST00000107693.2 ENSMUST00000107695.2 |
Trim2
|
tripartite motif-containing 2 |
chr9_+_74848437 | 0.77 |
ENSMUST00000161862.1
ENSMUST00000162089.1 ENSMUST00000160017.1 ENSMUST00000160950.1 |
Gm16551
Gm20649
|
predicted gene 16551 predicted gene 20649 |
chr12_-_40199315 | 0.76 |
ENSMUST00000095760.2
|
Lsmem1
|
leucine-rich single-pass membrane protein 1 |
chr13_-_23683941 | 0.76 |
ENSMUST00000171127.1
|
Hist1h2ac
|
histone cluster 1, H2ac |
chr1_+_93235836 | 0.75 |
ENSMUST00000062202.7
|
Sned1
|
sushi, nidogen and EGF-like domains 1 |
chr5_-_31291026 | 0.74 |
ENSMUST00000041565.7
|
Ift172
|
intraflagellar transport 172 |
chr3_+_96221111 | 0.74 |
ENSMUST00000090781.6
|
Hist2h2be
|
histone cluster 2, H2be |
chr7_-_102099932 | 0.73 |
ENSMUST00000106934.1
|
Art5
|
ADP-ribosyltransferase 5 |
chr1_-_91459254 | 0.72 |
ENSMUST00000069620.8
|
Per2
|
period circadian clock 2 |
chr1_-_168431695 | 0.72 |
ENSMUST00000176790.1
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chr10_-_64090265 | 0.72 |
ENSMUST00000105439.1
|
Lrrtm3
|
leucine rich repeat transmembrane neuronal 3 |
chr6_-_13839916 | 0.72 |
ENSMUST00000060442.7
|
Gpr85
|
G protein-coupled receptor 85 |
chr19_+_16435616 | 0.70 |
ENSMUST00000025602.2
|
Gna14
|
guanine nucleotide binding protein, alpha 14 |
chr17_-_90455872 | 0.70 |
ENSMUST00000174337.1
ENSMUST00000172466.1 |
Nrxn1
|
neurexin I |
chr13_+_42680565 | 0.70 |
ENSMUST00000128646.1
|
Phactr1
|
phosphatase and actin regulator 1 |
chr16_-_92697315 | 0.69 |
ENSMUST00000168195.1
ENSMUST00000113956.3 |
Runx1
|
runt related transcription factor 1 |
chr17_-_28486082 | 0.69 |
ENSMUST00000079413.3
|
Fkbp5
|
FK506 binding protein 5 |
chr6_+_88724667 | 0.68 |
ENSMUST00000163271.1
|
Mgll
|
monoglyceride lipase |
chr2_-_18048784 | 0.68 |
ENSMUST00000142856.1
|
Skida1
|
SKI/DACH domain containing 1 |
chr14_-_124677089 | 0.68 |
ENSMUST00000095529.3
|
Fgf14
|
fibroblast growth factor 14 |
chr17_-_35909626 | 0.67 |
ENSMUST00000141132.1
|
Atat1
|
alpha tubulin acetyltransferase 1 |
chr7_+_122289297 | 0.67 |
ENSMUST00000064989.5
ENSMUST00000064921.4 |
Prkcb
|
protein kinase C, beta |
chr17_-_27133902 | 0.66 |
ENSMUST00000119227.1
ENSMUST00000025045.8 |
Uqcc2
|
ubiquinol-cytochrome c reductase complex assembly factor 2 |
chr4_-_62434722 | 0.65 |
ENSMUST00000107454.1
|
Rnf183
|
ring finger protein 183 |
chr5_+_66968559 | 0.65 |
ENSMUST00000127184.1
|
Limch1
|
LIM and calponin homology domains 1 |
chr4_+_102254993 | 0.64 |
ENSMUST00000106908.2
|
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr2_+_30595037 | 0.64 |
ENSMUST00000102853.3
|
Cstad
|
CSA-conditional, T cell activation-dependent protein |
chr5_-_5265224 | 0.63 |
ENSMUST00000115450.1
|
Cdk14
|
cyclin-dependent kinase 14 |
chr6_-_65144908 | 0.63 |
ENSMUST00000031982.4
|
Hpgds
|
hematopoietic prostaglandin D synthase |
chr4_+_3678108 | 0.62 |
ENSMUST00000041377.6
ENSMUST00000103010.3 |
Lyn
|
Yamaguchi sarcoma viral (v-yes-1) oncogene homolog |
chr4_-_152477433 | 0.62 |
ENSMUST00000159186.1
ENSMUST00000162017.1 ENSMUST00000030768.2 |
Kcnab2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chr12_-_86988676 | 0.59 |
ENSMUST00000095521.2
|
Zdhhc22
|
zinc finger, DHHC-type containing 22 |
chr3_+_130180882 | 0.58 |
ENSMUST00000106353.1
ENSMUST00000080335.4 |
Col25a1
|
collagen, type XXV, alpha 1 |
chr3_-_97297778 | 0.57 |
ENSMUST00000181368.1
|
Gm17608
|
predicted gene, 17608 |
chr1_+_143640664 | 0.57 |
ENSMUST00000038252.2
|
B3galt2
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
chr14_+_45219993 | 0.57 |
ENSMUST00000146150.1
|
Gpr137c
|
G protein-coupled receptor 137C |
chr9_+_104569671 | 0.57 |
ENSMUST00000057742.8
|
Cpne4
|
copine IV |
chr2_-_38926217 | 0.56 |
ENSMUST00000076275.4
ENSMUST00000142130.1 |
Nr6a1
|
nuclear receptor subfamily 6, group A, member 1 |
chr1_-_126830632 | 0.56 |
ENSMUST00000112583.1
ENSMUST00000094609.3 |
Nckap5
|
NCK-associated protein 5 |
chr13_-_54688264 | 0.56 |
ENSMUST00000150626.1
ENSMUST00000134177.1 |
Rnf44
|
ring finger protein 44 |
chr9_+_104569754 | 0.56 |
ENSMUST00000077190.6
|
Cpne4
|
copine IV |
chr1_+_34579693 | 0.55 |
ENSMUST00000052670.8
|
Amer3
|
APC membrane recruitment 3 |
chr1_+_93373874 | 0.54 |
ENSMUST00000058682.4
|
Ano7
|
anoctamin 7 |
chrX_+_103321398 | 0.53 |
ENSMUST00000033689.2
|
Cdx4
|
caudal type homeobox 4 |
chr11_+_103103051 | 0.53 |
ENSMUST00000152971.1
|
Acbd4
|
acyl-Coenzyme A binding domain containing 4 |
chrX_-_167209149 | 0.52 |
ENSMUST00000112176.1
|
Tmsb4x
|
thymosin, beta 4, X chromosome |
chr5_+_66968961 | 0.52 |
ENSMUST00000132991.1
|
Limch1
|
LIM and calponin homology domains 1 |
chr8_-_87959560 | 0.52 |
ENSMUST00000109655.2
|
Zfp423
|
zinc finger protein 423 |
chr13_+_23574381 | 0.52 |
ENSMUST00000090776.4
|
Hist1h2ad
|
histone cluster 1, H2ad |
chr2_+_69135799 | 0.52 |
ENSMUST00000041865.7
|
Nostrin
|
nitric oxide synthase trafficker |
chr4_+_43562672 | 0.51 |
ENSMUST00000167751.1
ENSMUST00000132631.1 |
Creb3
|
cAMP responsive element binding protein 3 |
chr13_-_41358990 | 0.50 |
ENSMUST00000163623.1
|
Nedd9
|
neural precursor cell expressed, developmentally down-regulated gene 9 |
chr19_+_56287943 | 0.50 |
ENSMUST00000166049.1
|
Habp2
|
hyaluronic acid binding protein 2 |
chr18_+_50051702 | 0.50 |
ENSMUST00000134348.1
ENSMUST00000153873.2 |
Tnfaip8
|
tumor necrosis factor, alpha-induced protein 8 |
chr13_+_40917626 | 0.50 |
ENSMUST00000067778.6
|
Gcnt2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
chr13_+_22035821 | 0.49 |
ENSMUST00000110455.2
|
Hist1h2bk
|
histone cluster 1, H2bk |
chr10_+_118860826 | 0.49 |
ENSMUST00000059966.4
|
4932442E05Rik
|
RIKEN cDNA 4932442E05 gene |
chrX_-_57338598 | 0.49 |
ENSMUST00000033468.4
ENSMUST00000114736.1 |
Arhgef6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
chr10_-_115362191 | 0.48 |
ENSMUST00000092170.5
|
Tmem19
|
transmembrane protein 19 |
chr9_+_78175898 | 0.48 |
ENSMUST00000180974.1
|
C920006O11Rik
|
RIKEN cDNA C920006O11 gene |
chr19_+_55741810 | 0.48 |
ENSMUST00000111657.3
ENSMUST00000061496.9 ENSMUST00000041717.7 ENSMUST00000111662.4 |
Tcf7l2
|
transcription factor 7 like 2, T cell specific, HMG box |
chr5_-_122989086 | 0.48 |
ENSMUST00000046073.9
|
Kdm2b
|
lysine (K)-specific demethylase 2B |
chr13_+_40886758 | 0.47 |
ENSMUST00000069958.7
|
Gcnt2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
chr7_+_91090728 | 0.47 |
ENSMUST00000074273.3
|
Dlg2
|
discs, large homolog 2 (Drosophila) |
chr11_-_96747405 | 0.47 |
ENSMUST00000180492.1
|
2010300F17Rik
|
RIKEN cDNA 2010300F17 gene |
chr6_-_142278836 | 0.47 |
ENSMUST00000111825.3
|
Slco1a5
|
solute carrier organic anion transporter family, member 1a5 |
chr6_+_88724828 | 0.47 |
ENSMUST00000089449.2
|
Mgll
|
monoglyceride lipase |
chr10_+_79927330 | 0.46 |
ENSMUST00000105376.1
|
Arid3a
|
AT rich interactive domain 3A (BRIGHT-like) |
chr2_+_28192971 | 0.46 |
ENSMUST00000113920.1
|
Olfm1
|
olfactomedin 1 |
chr4_-_128806045 | 0.46 |
ENSMUST00000106072.2
ENSMUST00000170934.1 |
Zfp362
|
zinc finger protein 362 |
chr10_+_39612934 | 0.45 |
ENSMUST00000019987.6
|
Traf3ip2
|
TRAF3 interacting protein 2 |
chr5_+_111417263 | 0.45 |
ENSMUST00000094463.4
|
Mn1
|
meningioma 1 |
chr10_+_128706251 | 0.45 |
ENSMUST00000054125.8
|
Pmel
|
premelanosome protein |
chr5_-_101665195 | 0.44 |
ENSMUST00000044125.8
|
Nkx6-1
|
NK6 homeobox 1 |
chr10_+_67535465 | 0.44 |
ENSMUST00000145754.1
|
Egr2
|
early growth response 2 |
chr2_+_143546144 | 0.44 |
ENSMUST00000028905.9
|
Pcsk2
|
proprotein convertase subtilisin/kexin type 2 |
chr13_-_54688184 | 0.43 |
ENSMUST00000150806.1
ENSMUST00000125927.1 |
Rnf44
|
ring finger protein 44 |
chr17_-_34882004 | 0.43 |
ENSMUST00000152417.1
ENSMUST00000146299.1 |
C2
Gm20547
|
complement component 2 (within H-2S) predicted gene 20547 |
chr1_+_42952872 | 0.43 |
ENSMUST00000179766.1
|
Gpr45
|
G protein-coupled receptor 45 |
chr19_-_37176055 | 0.43 |
ENSMUST00000142973.1
ENSMUST00000154376.1 |
Cpeb3
|
cytoplasmic polyadenylation element binding protein 3 |
chr11_+_108920800 | 0.42 |
ENSMUST00000140821.1
|
Axin2
|
axin2 |
chr6_-_56901870 | 0.42 |
ENSMUST00000101367.2
|
Nt5c3
|
5'-nucleotidase, cytosolic III |
chr3_-_144819494 | 0.42 |
ENSMUST00000029929.7
|
Clca2
|
chloride channel calcium activated 2 |
chr7_+_91090697 | 0.41 |
ENSMUST00000107196.2
|
Dlg2
|
discs, large homolog 2 (Drosophila) |
chr11_-_96747419 | 0.40 |
ENSMUST00000181758.1
|
2010300F17Rik
|
RIKEN cDNA 2010300F17 gene |
chr16_+_17233560 | 0.40 |
ENSMUST00000090190.5
ENSMUST00000115698.2 |
Hic2
|
hypermethylated in cancer 2 |
chr13_+_23684192 | 0.39 |
ENSMUST00000018246.4
|
Hist1h2bc
|
histone cluster 1, H2bc |
chr15_+_6579841 | 0.39 |
ENSMUST00000090461.5
|
Fyb
|
FYN binding protein |
chr19_+_20601958 | 0.39 |
ENSMUST00000087638.3
|
Aldh1a1
|
aldehyde dehydrogenase family 1, subfamily A1 |
chr7_-_44997535 | 0.39 |
ENSMUST00000124232.1
ENSMUST00000003290.4 |
Bcl2l12
|
BCL2-like 12 (proline rich) |
chr5_+_146231211 | 0.38 |
ENSMUST00000161181.1
ENSMUST00000161652.1 ENSMUST00000031640.8 ENSMUST00000159467.1 |
Cdk8
|
cyclin-dependent kinase 8 |
chr3_+_31902507 | 0.37 |
ENSMUST00000119310.1
|
Kcnmb2
|
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
chr1_-_144004142 | 0.37 |
ENSMUST00000127206.1
|
Rgs2
|
regulator of G-protein signaling 2 |
chr17_-_24533709 | 0.37 |
ENSMUST00000061764.7
|
Rab26
|
RAB26, member RAS oncogene family |
chr17_-_15375969 | 0.37 |
ENSMUST00000014917.7
|
Dll1
|
delta-like 1 (Drosophila) |
chr9_+_124102110 | 0.36 |
ENSMUST00000168841.1
ENSMUST00000055918.6 |
Ccr2
|
chemokine (C-C motif) receptor 2 |
chr4_+_43632185 | 0.36 |
ENSMUST00000107874.2
|
Npr2
|
natriuretic peptide receptor 2 |
chr13_-_23574196 | 0.36 |
ENSMUST00000105106.1
|
Hist1h2bf
|
histone cluster 1, H2bf |
chr3_+_96269695 | 0.36 |
ENSMUST00000051089.3
ENSMUST00000177113.1 |
Hist2h2bb
|
histone cluster 2, H2bb |
chr11_+_90030295 | 0.36 |
ENSMUST00000092788.3
|
Tmem100
|
transmembrane protein 100 |
chr9_+_89199319 | 0.36 |
ENSMUST00000138109.1
|
Mthfs
|
5, 10-methenyltetrahydrofolate synthetase |
chr13_-_23934156 | 0.35 |
ENSMUST00000052776.2
|
Hist1h2ba
|
histone cluster 1, H2ba |
chr11_+_101367542 | 0.35 |
ENSMUST00000019469.2
|
G6pc
|
glucose-6-phosphatase, catalytic |
chr1_-_190169399 | 0.35 |
ENSMUST00000010319.7
|
Prox1
|
prospero-related homeobox 1 |
chr13_+_97241096 | 0.35 |
ENSMUST00000041623.7
|
Enc1
|
ectodermal-neural cortex 1 |
chr3_+_83766300 | 0.35 |
ENSMUST00000029625.7
|
Sfrp2
|
secreted frizzled-related protein 2 |
chr11_+_69838514 | 0.35 |
ENSMUST00000133967.1
ENSMUST00000094065.4 |
Tmem256
|
transmembrane protein 256 |
chr1_-_66817536 | 0.35 |
ENSMUST00000068168.3
ENSMUST00000113987.1 |
Kansl1l
|
KAT8 regulatory NSL complex subunit 1-like |
chr11_-_100527896 | 0.35 |
ENSMUST00000107389.1
ENSMUST00000007131.9 |
Acly
|
ATP citrate lyase |
chr11_+_74830920 | 0.35 |
ENSMUST00000000291.2
|
Mnt
|
max binding protein |
chr13_+_113209659 | 0.34 |
ENSMUST00000038144.8
|
Esm1
|
endothelial cell-specific molecule 1 |
chr2_+_57238297 | 0.34 |
ENSMUST00000112618.2
ENSMUST00000028167.2 |
Gpd2
|
glycerol phosphate dehydrogenase 2, mitochondrial |
chr13_+_22043189 | 0.34 |
ENSMUST00000110452.1
|
Hist1h2bj
|
histone cluster 1, H2bj |
chr5_-_148928619 | 0.33 |
ENSMUST00000149169.1
ENSMUST00000047257.8 |
Katnal1
|
katanin p60 subunit A-like 1 |
chr11_-_48817332 | 0.33 |
ENSMUST00000047145.7
|
Trim41
|
tripartite motif-containing 41 |
chr3_+_31902666 | 0.33 |
ENSMUST00000119970.1
ENSMUST00000178668.1 |
Kcnmb2
|
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
chr12_+_52699297 | 0.33 |
ENSMUST00000095737.3
|
Akap6
|
A kinase (PRKA) anchor protein 6 |
chr10_-_8886033 | 0.33 |
ENSMUST00000015449.5
|
Sash1
|
SAM and SH3 domain containing 1 |
chr4_+_105157339 | 0.33 |
ENSMUST00000064139.7
|
Ppap2b
|
phosphatidic acid phosphatase type 2B |
chr8_+_70234613 | 0.33 |
ENSMUST00000145078.1
|
Sugp2
|
SURP and G patch domain containing 2 |
chr19_+_6400523 | 0.32 |
ENSMUST00000146831.1
ENSMUST00000035716.8 ENSMUST00000138555.1 ENSMUST00000167240.1 |
Rasgrp2
|
RAS, guanyl releasing protein 2 |
chr10_+_97479470 | 0.32 |
ENSMUST00000105287.3
|
Dcn
|
decorin |
chr9_-_102354685 | 0.32 |
ENSMUST00000035129.7
ENSMUST00000085169.5 |
Ephb1
|
Eph receptor B1 |
chr8_-_122678653 | 0.32 |
ENSMUST00000134045.1
|
Cbfa2t3
|
core-binding factor, runt domain, alpha subunit 2, translocated to, 3 (human) |
chr7_-_44997221 | 0.31 |
ENSMUST00000152341.1
|
Bcl2l12
|
BCL2-like 12 (proline rich) |
chr2_+_105675478 | 0.31 |
ENSMUST00000167211.2
ENSMUST00000111083.3 |
Pax6
|
paired box gene 6 |
chr12_+_76404168 | 0.31 |
ENSMUST00000080449.5
|
Hspa2
|
heat shock protein 2 |
chr7_+_45017953 | 0.31 |
ENSMUST00000044111.7
|
Rras
|
Harvey rat sarcoma oncogene, subgroup R |
chr19_+_26750939 | 0.30 |
ENSMUST00000175953.1
|
Smarca2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr11_+_98741805 | 0.30 |
ENSMUST00000064187.5
|
Thra
|
thyroid hormone receptor alpha |
chr1_-_135258449 | 0.30 |
ENSMUST00000003135.7
|
Elf3
|
E74-like factor 3 |
chr10_+_42860776 | 0.30 |
ENSMUST00000105494.1
|
Scml4
|
sex comb on midleg-like 4 (Drosophila) |
chr13_-_54688065 | 0.30 |
ENSMUST00000125871.1
|
Rnf44
|
ring finger protein 44 |
chr6_+_92092369 | 0.30 |
ENSMUST00000113463.1
|
Nr2c2
|
nuclear receptor subfamily 2, group C, member 2 |
chr19_-_20727533 | 0.30 |
ENSMUST00000025656.3
|
Aldh1a7
|
aldehyde dehydrogenase family 1, subfamily A7 |
chr7_+_120982521 | 0.29 |
ENSMUST00000149535.1
ENSMUST00000138177.1 |
4933427G17Rik
|
RIKEN cDNA 4933427G17 gene |
chr2_+_109917639 | 0.29 |
ENSMUST00000046548.7
ENSMUST00000111037.2 |
Lgr4
|
leucine-rich repeat-containing G protein-coupled receptor 4 |
chr10_-_25200110 | 0.29 |
ENSMUST00000100012.2
|
Akap7
|
A kinase (PRKA) anchor protein 7 |
chr8_+_45627709 | 0.29 |
ENSMUST00000134321.1
ENSMUST00000135336.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr13_-_22042949 | 0.28 |
ENSMUST00000091741.4
|
Hist1h2ag
|
histone cluster 1, H2ag |
chr13_-_22035589 | 0.28 |
ENSMUST00000091742.4
|
Hist1h2ah
|
histone cluster 1, H2ah |
chr17_+_27057288 | 0.28 |
ENSMUST00000049308.8
|
Itpr3
|
inositol 1,4,5-triphosphate receptor 3 |
chr1_+_152750527 | 0.28 |
ENSMUST00000068875.4
|
Apobec4
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 4 (putative) |
chr4_-_137118135 | 0.28 |
ENSMUST00000154285.1
|
Gm13001
|
predicted gene 13001 |
chr13_-_54688246 | 0.27 |
ENSMUST00000122935.1
ENSMUST00000128257.1 |
Rnf44
|
ring finger protein 44 |
chr2_-_161109017 | 0.27 |
ENSMUST00000039782.7
ENSMUST00000134178.1 |
Chd6
|
chromodomain helicase DNA binding protein 6 |
chr11_-_29247208 | 0.27 |
ENSMUST00000020754.3
|
Ccdc104
|
coiled-coil domain containing 104 |
chr14_-_66868572 | 0.27 |
ENSMUST00000022629.8
|
Dpysl2
|
dihydropyrimidinase-like 2 |
chr10_-_81350389 | 0.27 |
ENSMUST00000020454.4
ENSMUST00000105324.2 ENSMUST00000154609.2 ENSMUST00000105323.1 |
Hmg20b
|
high mobility group 20B |
chr2_-_18048347 | 0.26 |
ENSMUST00000066885.5
|
Skida1
|
SKI/DACH domain containing 1 |
chr6_+_145121727 | 0.26 |
ENSMUST00000032396.6
|
Lrmp
|
lymphoid-restricted membrane protein |
chr19_-_37178011 | 0.26 |
ENSMUST00000133988.1
|
Cpeb3
|
cytoplasmic polyadenylation element binding protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.1 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.4 | 1.3 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.4 | 1.6 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.3 | 1.0 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.3 | 1.0 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.2 | 0.7 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.2 | 0.7 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.2 | 0.7 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.2 | 0.7 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.2 | 2.7 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.6 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.2 | 0.7 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.2 | 0.5 | GO:0019043 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) establishment of viral latency(GO:0019043) release from viral latency(GO:0019046) |
0.2 | 1.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.2 | 0.6 | GO:0021664 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.2 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 0.9 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.4 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.1 | 1.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.1 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.1 | 2.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.4 | GO:0002436 | immune complex clearance by monocytes and macrophages(GO:0002436) astrocyte chemotaxis(GO:0035700) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) negative regulation of eosinophil activation(GO:1902567) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) |
0.1 | 0.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.4 | GO:0060844 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
0.1 | 0.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.4 | GO:0090425 | hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.1 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.1 | 0.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.3 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.1 | 1.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.2 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.4 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.1 | 0.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 2.7 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 0.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.7 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.2 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.1 | 1.2 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.6 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 0.2 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.4 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 1.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.7 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 2.3 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.6 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.9 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.6 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.4 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.2 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.1 | 0.7 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.1 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 1.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 1.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.0 | 4.8 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.2 | GO:1990743 | protein sialylation(GO:1990743) |
0.0 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.0 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.2 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.0 | 1.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.9 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.0 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.4 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.0 | 1.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.3 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.5 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 1.5 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 1.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.5 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.0 | GO:0060003 | copper ion export(GO:0060003) |
0.0 | 1.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.0 | 0.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.0 | 1.8 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.0 | 0.0 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.0 | 0.1 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.3 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 2.8 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.0 | GO:1902938 | modulation of age-related behavioral decline(GO:0090647) regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.0 | 0.3 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.0 | GO:0061235 | regulation of pronephros size(GO:0035565) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesonephric duct formation(GO:0072181) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
0.0 | 0.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 2.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.7 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 0.6 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 1.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 4.7 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 1.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.4 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.0 | 2.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 1.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.0 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 1.8 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.3 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.7 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 1.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0032437 | spectrin(GO:0008091) cuticular plate(GO:0032437) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 1.1 | GO:0005814 | centriole(GO:0005814) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 1.0 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.3 | 0.9 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.3 | 1.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 1.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 0.9 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 2.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 0.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.6 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 0.4 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.1 | 2.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.4 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.1 | 0.4 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 1.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.4 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.1 | 0.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.3 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.1 | 0.3 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 1.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 1.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 1.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 1.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.0 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 5.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 2.3 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 2.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 1.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.0 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.0 | 0.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 3.2 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 2.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 2.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 1.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 3.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 2.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 2.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 1.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 1.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 1.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 1.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 1.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |